In a Phoenix hospital's records, a quiet pattern has surfaced: women from Native American and Hispanic communities were being found with uterine cancer roughly a decade earlier than their White and non-Hispanic peers. The disease, long imagined as belonging to later life, is reminding us that the body's timing is shaped by metabolism, circumstance, and the distances people must travel to be heard. Researchers are now asking the harder question of who we have been failing to look for, and how early we might learn to look.
Native American and Hispanic Women Diagnosed With Endometrial Cancer at Markedly Younger Ages
Uterine cancers are expected to cause more than 14,000 deaths in the U.S. in 2026, and late diagnoses contribute to more deaths than ovarian cancer.
Not every case is caught early, and 14,000 deaths are expected in 2026
Mark
The headline number is about a decade. Native American women diagnosed at 49.8, White women at 62. Why does that gap matter so much?
Mimi
Because the usual picture of this cancer is an older, postmenopausal woman. If a woman in her late forties doesn't fit that picture, her symptoms may not get taken as seriously, by her or by her providers.
Luke
Worth noting the sample, though. 168 cancer patients at one Phoenix hospital. The article doesn't break down how many were Native American or Hispanic, so I can't tell you how solid those averages are.
Mark
The lead author said as much, didn't she?
Mimi
Yes. Herbst-Kralovetz said it's retrospective and needs confirmation in larger groups.
Mark
The study points to diabetes, 45% among Native American patients and 21% among Hispanic patients. Is that the explanation?
Luke
Not by itself. Diabetes and obesity are described as primary drivers of the disease, but the researchers themselves say metabolic health isn't the whole story. The study doesn't show what causes the age gap.
Mimi
The social vulnerability data adds another layer: housing trouble, transportation trouble, no vehicle. Those are barriers to getting seen.
Luke
Careful there. Patients with cancer were more likely to live in those areas, which is an association. The reporting doesn't say those barriers delayed any particular diagnosis.
Mark
So what's the practical hope?
Mimi
A simple, less invasive test that skips the tissue biopsy and could be offered in primary care and rural clinics.
Luke
And that's still in development. Nothing here says it's validated or available yet.
Der Puls
- Native American patients were diagnosed at an average age near 50, roughly a dozen years before White patients, shaking assumptions about who this cancer strikes.
- Nearly half of Native American patients in the study lived with diabetes, a condition tied to the hormonal changes that can drive uterine growth.
- Patients were more likely to face crowded housing, lack of a vehicle, and hard-to-reach care, turning distance itself into a obstacle to diagnosis.
- Researchers are pushing for larger confirmatory studies and a simple, non-biopsy test that primary care and rural clinics could offer.
- With uterine cancers expected to claim over 14,000 lives in 2026, the race to detect it earlier is landing as a question of who gets tested in time.
In a Phoenix hospital's records, a quiet pattern has surfaced: women from Native American and Hispanic communities were being found with uterine cancer roughly a decade earlier than their White and non-Hispanic peers. The disease, long imagined as belonging to later life, is reminding us that the body's timing is shaped by metabolism, circumstance, and the distances people must travel to be heard. Researchers are now asking the harder question of who we have been failing to look for, and how early we might learn to look.
At Banner – University Medical Center Phoenix, researchers from the University of Arizona Cancer Center reviewed the records of 261 women who had gynecologic surgery between 2016 and 2021. Among them, 168 had endometrial cancer, the most common form of uterine cancer. When the team sorted these patients by race and ethnicity, a clear pattern emerged: Native American and Hispanic women were diagnosed years earlier than their counterparts.
Native American patients were diagnosed at an average age of 49.8, compared with 62 for White patients. Hispanic patients averaged 53.7, compared with 61.6 for non-Hispanic patients. The findings appeared in the journal Cancer Medicine.
The lead author, Melissa Herbst-Kralovetz, said the results challenge the belief that this is mainly a disease of older women. "We need to rethink who we consider at risk," she said. Diabetes was present in 45% of Native American patients and 21% of Hispanic patients, and metabolic conditions, along with social hardship such as housing instability and lack of transportation, appeared to intersect with the disease.
The study has limits, including its retrospective design and single site, and its authors want larger studies to confirm the findings. Herbst-Kralovetz's lab is developing a less invasive test that could detect the cancer without a tissue biopsy, with the goal of bringing it to primary care and rural clinics, so that diagnosis can happen while treatment can still cure.
At Banner – University Medical Center Phoenix, researchers from the University of Arizona Cancer Center went back through the records of 261 women who had gynecologic surgery between 2016 and 2021. Of those, 168 had endometrial cancer. When the team sorted those 168 by race and ethnicity, the ages at diagnosis told a clear story: Native American and Hispanic women were being diagnosed years earlier than their counterparts.
Native American patients were diagnosed at an average age of 49.8, compared with 62 for White patients. Hispanic patients averaged 53.7, compared with 61.6 for non-Hispanic patients. The findings were published in the journal Cancer Medicine.
Endometrial cancer starts in the lining of the uterus, the tissue that thickens and sheds under hormonal control during the menstrual cycle. It is the most common type of uterine cancer, and while incidence of some cancers in women has fallen, this one has risen substantially over the past two decades. The American Cancer Society reports that rates in the United States climbed between 1.8% and 2.6% per year from 2013 to 2022, with recent trends showing some stabilization. Current estimates run to about 68,270 new cases a year.
The stakes depend heavily on timing. When the cancer is found before it spreads beyond the uterus, five-year survival is roughly 95%. But not every case is caught that early, and cancers of the uterus are expected to kill more than 14,000 people in the U.S. in 2026. High incidence combined with late diagnosis means the disease contributes to more deaths each year than ovarian cancer.
Melissa Herbst-Kralovetz, the study's lead author and a professor of basic medical sciences at the U of A College of Medicine – Phoenix, said the results challenge the idea that this is mainly a disease of older, postmenopausal women. "We need to rethink who we consider at risk," she said. Patricia Thompson, deputy director of the Cancer Center, pointed to a 2026 evidence review from the Society of Gynecologic Oncology that flagged delayed evaluation of abnormal bleeding in premenopausal women. In the research it cited, 36% experienced delays of more than six months before undergoing endometrial sampling.
The study also looked at possible contributors. Diabetes was present in 45% of the Native American patients and 21% of the Hispanic patients. Obesity and diabetes are among the primary drivers of the disease, Herbst-Kralovetz explained, because fatty tissue is hormonally active and produces estrogen, and metabolic conditions can foster abnormal growth in the uterine lining. She cautioned that metabolic health alone is not the whole picture, and that environmental, biological and social factors likely intersect.
To probe the social side, the team used the Arizona Social Vulnerability Index, which draws on census data to gauge the hardships of underserved areas. Patients with cancer were more likely to live where housing and transportation are difficult, more likely to lack a vehicle, and more likely to live in crowded housing.
The study has limits. It is retrospective and drew on a single medical center, and Herbst-Kralovetz said the results need confirmation in larger groups. Her lab, meanwhile, is working on a simple, less invasive test that could detect endometrial cancer without a tissue biopsy, with the aim of offering it through primary care offices, especially in rural and underserved communities. She wants more investment in validating such tests and in partnerships with rural health care providers, so that diagnosis happens when treatment can cure.
Bemerkenswerte Zitate
We need to rethink who we consider at risk for endometrial cancer.— Melissa Herbst-Kralovetz, lead author, University of Arizona College of Medicine – Phoenix
Earlier detection offers an important opportunity to reduce deaths from a cancer that is highly treatable when diagnosed at an early stage.— Patricia Thompson, deputy director, University of Arizona Cancer Center
Möchten Sie die ganze Geschichte?
Das Original lesen bei News-Medical ↗